Clinical Trial Update: A Proof of Concept Study Assessing the Effect of Four Different Single Bolus Intravenous Doses of FE200440 and Placebo on Stopping Preterm Labor [Phase 2]

View source ↗

Summary

A Phase 2 proof-of-concept trial assessing four single-bolus intravenous doses of FE200440 versus placebo for stopping preterm labor; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Preterm Birth
• Preterm Labor

Drugs mentioned

• FE200440 (FE200440)

Snippet

Sponsor: Ferring Pharmaceuticals | Conditions: Labor, Premature, Premature Birth | Phase 2 | Status: COMPLETED